Search

everythinglearnresearchcommunity

for

Search:↓

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Skin symptoms often reveal hormonal imbalances in PCOS.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Meloside A may help protect hair cells from damage linked to hair loss.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Surgery successfully treated a hidden ovarian tumor causing hair loss and excess hair growth in a postmenopausal woman.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

CEC levels may be a useful marker for predicting prostate cancer progression.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Androgens and other hormones affect hair growth and skin conditions like acne.

No link between hair loss and blood groups or Rhesus factor.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.